Volex (AIM: VLX) upgrades FY2026 revenue to at least $1.22bn as AI data centre demand doubles and board eyes Main Market move
Can inhaled nintedanib improve tolerability and adherence in IPF treatment, according to Avalyn Pharma Inc.?
Read More 5 minute read Healthcare Industry News Inside Johnson & Johnson’s $966m talc verdict: how one case could reshape its future battles Find out how Johnson & Johnson’s $966 million talc cancer verdict could reshape its litigation strategy, investor sentiment, and brand credibility. bySrinathOctober 7, 2025